Overview: Examines the regulatory review practices in the seven Gulf Cooperation Council states, namely Kuwait, Iraq, Bahrain, Oman, Qatar, Saudi Arabia and the United Arab Emirates.Compares national metrics wi.This book compares national and centralised procedure practices and key performance metrics, including current approval times, review practices and pharmacovigilance standards, in the seven Gulf States. Opportunities for an improved regulatory system are identified, which, if fully implemented, could have a significant impact on patients’ access to new medicines..The Persian Gulf repres
|